SPOTLIGHT: Top 10 drug warnings and recalls of 2007

2007 was a year of high-profile drug safety warnings. Check out this report for a look at the 10 biggest drugs--ranked by 2006 sales--that drew new, FDA-issued warnings or withdrawals. Special report

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.